Skip to the page

Data / Form D filings / ATED Therapeutics Ltd.

ATED Therapeutics Ltd.: Form D filing

ATED Therapeutics Ltd., a health care company in Greenwich, CT, filed a Form D with the SEC in 2026. The latest, on April 2, 2026, reports $670,000 sold of a $670,000 offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
ONE SOUND SHORE DRIVE SUITE 103, Greenwich, CT, 06830
Phone
(203) 569-6825
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Israel
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2114239

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 2, 2026New notice$670,000$670,00013Oct 24, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jeff R. SwarzExecutive Officer, Director
Joseph ChiarelliExecutive Officer, Director

Other health care companies in Connecticut that filed recently

Every Form D from the week of Mar 30, 2026 · All recent filings in Connecticut · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ATED Therapeutics Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.